China Biologic Products ROE 2009-2019 | CBPO

Current and historical return on equity (ROE) values for China Biologic Products (CBPO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. China Biologic Products ROE for the three months ending December 31, 2019 was 9.33%.
China Biologic Products ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-12-31 $0.14B $1.78B 7.65%
2019-09-30 $0.16B $1.73B 8.73%
2019-06-30 $0.15B $1.83B 7.88%
2019-03-31 $0.13B $1.88B 7.80%
2018-12-31 $0.13B $1.85B 8.24%
2018-09-30 $0.07B $1.81B 5.43%
2018-06-30 $0.07B $1.23B 6.96%
2018-03-31 $0.07B $1.23B 8.56%
2017-12-31 $0.07B $0.66B 10.54%
2017-09-30 $0.11B $0.67B 18.80%
2017-06-30 $0.11B $0.62B 18.90%
2017-03-31 $0.11B $0.56B 19.41%
2016-12-31 $0.10B $0.52B 19.17%
2016-09-30 $0.10B $0.57B 19.09%
2016-06-30 $0.09B $0.54B 19.01%
2016-03-31 $0.09B $0.50B 19.50%
2015-12-31 $0.09B $0.47B 21.12%
2015-09-30 $0.09B $0.45B 23.35%
2015-06-30 $0.08B $0.43B 26.27%
2015-03-31 $0.08B $0.31B 27.02%
2014-12-31 $0.07B $0.28B 26.42%
2014-09-30 $0.07B $0.26B 23.91%
2014-06-30 $0.06B $0.29B 21.38%
2014-03-31 $0.06B $0.26B 19.67%
2013-12-31 $0.05B $0.30B 18.29%
2013-09-30 $0.05B $0.30B 18.34%
2013-06-30 $0.05B $0.30B 18.78%
2013-03-31 $0.05B $0.28B 19.01%
2012-12-31 $0.05B $0.26B 19.76%
2012-09-30 $0.05B $0.25B 21.10%
2012-06-30 $0.02B $0.23B 11.25%
2012-03-31 $0.03B $0.20B 14.13%
2011-12-31 $0.02B $0.18B 11.16%
2011-09-30 $0.01B $0.18B 4.95%
2011-06-30 $0.03B $0.18B 20.43%
2011-03-31 $0.03B $0.14B 19.85%
2010-12-31 $0.03B $0.15B 25.65%
2010-09-30 $0.03B $0.14B 31.05%
2010-06-30 $0.01B $0.12B 14.70%
2010-03-31 $0.01B $0.10B 9.41%
2009-12-31 $0.00B $0.08B 1.30%
2009-09-30 $0.01B $0.08B 12.08%
2009-06-30 $0.02B $0.08B 32.73%
2009-03-31 $0.01B $0.07B 30.23%
2008-12-31 $0.01B $0.04B 33.33%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $4.023B $0.504B
China Biologic Products, Inc., through its indirect majority-owned subsidiary, is principally engaged in the research, development, production, manufacturing and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China. Its subsidiary, Shandong Taibang Biological Products Co. Ltd., operates from its manufacturing facility located in Taian City, Shandong Province. The Company's principal products include its approved human albumin and immunoglobulin products. These human albumin products are mainly used to increase blood volume and its immunoglobulin products are used for the treatment and prevention of diseases.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $123.199B 14.09
Gilead Sciences (GILD) United States $96.919B 12.54
CSL (CSLLY) Australia $87.050B 0.00
Vertex Pharmaceuticals (VRTX) United States $62.784B 56.98
Regeneron Pharmaceuticals (REGN) United States $54.871B 23.24
Biogen (BIIB) United States $52.997B 9.05
Illumina (ILMN) United States $40.130B 41.49
Seattle Genetics (SGEN) United States $20.442B 0.00
Alexion Pharmaceuticals (ALXN) United States $20.067B 9.30
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.372B 0.00
Incyte (INCY) United States $16.707B 35.85
BioMarin Pharmaceutical (BMRN) United States $15.484B 662.00
Genmab (GMAB) Denmark $13.068B 10.25
BioNTech SE (BNTX) Germany $12.877B 0.00
Genmab (GNMSF) Denmark $12.366B 39.77
Galapagos (GLPG) Belgium $12.288B 26.84
Alnylam Pharmaceuticals (ALNY) United States $11.783B 0.00
Moderna (MRNA) United States $10.923B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.315B 48.21
QIAGEN (QGEN) Netherlands $9.133B 27.85
BeiGene (BGNE) Cayman Islands $8.882B 0.00
Exact Sciences (EXAS) United States $8.523B 0.00
Sarepta Therapeutics (SRPT) United States $7.465B 0.00
Bio-Techne Corp (TECH) United States $7.318B 50.08
ACADIA Pharmaceuticals (ACAD) United States $6.475B 0.00
Guardant Health (GH) United States $6.146B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.056B 16.00
ARGENX SE-ADR (ARGX) Netherlands $5.695B 0.00
Ascendis Pharma (ASND) Denmark $5.293B 0.00
Exelixis (EXEL) United States $5.085B 16.32
Repligen (RGEN) United States $5.050B 92.33
Reata Pharmaceuticals (RETA) United States $4.498B 0.00
Acceleron Pharma (XLRN) United States $4.459B 0.00
Adaptive Biotechnologies (ADPT) United States $3.553B 0.00
Mirati Therapeutics (MRTX) United States $3.278B 0.00
Blueprint Medicines (BPMC) United States $3.263B 0.00
Vir Biotechnology (VIR) United States $3.213B 0.00
MorphoSys AG (MOR) Germany $3.186B 0.00
Global Blood Therapeutics (GBT) United States $3.076B 0.00
Zai Lab (ZLAB) China $2.992B 0.00
Emergent Biosolutions (EBS) United States $2.966B 20.59
Ultragenyx Pharmaceutical (RARE) United States $2.896B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.845B 0.00
NeoGenomics (NEO) United States $2.834B 122.86
Amicus Therapeutics (FOLD) United States $2.472B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.404B 40.73
Bluebird Bio (BLUE) United States $2.370B 0.00
Halozyme Therapeutics (HALO) United States $2.329B 0.00
Immunomedics (IMMU) United States $2.278B 0.00
RA PHARMCTL INC (RARX) United States $2.272B 0.00
Alkermes (ALKS) Ireland $2.212B 175.25
Arena Pharmaceuticals (ARNA) United States $2.210B 5.76
MyoKardia (MYOK) United States $2.161B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.102B 0.00
UniQure (QURE) Netherlands $2.078B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.977B 0.00
Amarin (AMRN) Ireland $1.865B 0.00
Denali Therapeutics (DNLI) United States $1.839B 0.00
Alector (ALEC) United States $1.786B 0.00
Principia Biopharma (PRNB) United States $1.731B 0.00
Eidos Therapeutics (EIDX) United States $1.647B 0.00
Viela Bio (VIE) United States $1.631B 0.00
Fate Therapeutics (FATE) United States $1.600B 0.00
Arvinas (ARVN) United States $1.565B 0.00
Zymeworks (ZYME) Canada $1.563B 0.00
Akcea Therapeutics (AKCA) United States $1.463B 31.46
Epizyme (EPZM) United States $1.437B 0.00
Insmed (INSM) United States $1.357B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.350B 0.00
Ligand Pharmaceuticals (LGND) United States $1.188B 36.90
Zealand Pharma (ZEAL) Denmark $1.144B 0.00
PHARMA MAR SA (PHMMF) Spain $1.107B 0.00
Editas Medicine (EDIT) United States $1.096B 0.00
Inovio Pharmaceuticals (INO) United States $1.096B 0.00
REGENXBIO (RGNX) United States $1.093B 0.00
Coherus BioSciences (CHRS) United States $1.057B 12.57
Twist Bioscience (TWST) United States $1.055B 0.00
Myriad Genetics (MYGN) United States $0.992B 17.51
NextCure (NXTC) United States $0.987B 0.00
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
NGM Biopharmaceuticals (NGM) United States $0.866B 0.00
I-Mab (IMAB) China $0.827B 0.00
Intra-Cellular Therapies (ITCI) United States $0.795B 0.00
Sangamo Therapeutics (SGMO) United States $0.787B 0.00
Revance Therapeutics (RVNC) United States $0.779B 0.00
Beam Therapeutics (BEAM) United States $0.758B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.740B 0.00
Cytokineticsorporated (CYTK) United States $0.716B 0.00
Novavax (NVAX) United States $0.714B 0.00
Arcus Biosciences (RCUS) United States $0.685B 0.00
Adverum Biotechnologies (ADVM) United States $0.680B 0.00
Pharming Group (PHGUF) Netherlands $0.663B 0.00
Bellus Health (BLU) Canada $0.663B 0.00
Athenex (ATNX) United States $0.658B 0.00
Retrophin (RTRX) United States $0.648B 0.00
Kadmon Holdings (KDMN) United States $0.617B 0.00
Codexis (CDXS) United States $0.613B 0.00
Cara Therapeutics (CARA) United States $0.593B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.591B 5.20
Intellia Therapeutics (NTLA) United States $0.582B 0.00
GENFIT S.A (GNFT) France $0.577B 0.00
AC Immune SA (ACIU) Switzerland $0.512B 13.07
ZIOPHARM Oncology Inc (ZIOP) United States $0.509B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.501B 0.00
Compugen (CGEN) Israel $0.497B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.489B 0.00
Mesoblast (MESO) Australia $0.486B 0.00
Intrexon (PGEN) United States $0.485B 0.00
Castle Biosciences (CSTL) United States $0.477B 0.00
Frequency Therapeutics (FREQ) United States $0.474B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.469B 0.00
ANI Pharmaceuticals (ANIP) United States $0.469B 8.46
Heska (HSKA) United States $0.469B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.460B 0.00
Prothena (PRTA) Ireland $0.459B 0.00
Athersys (ATHX) United States $0.450B 0.00
Clovis Oncology (CLVS) United States $0.446B 0.00
MeiraGTx Holdings (MGTX) United States $0.434B 0.00
Morphic Holding (MORF) United States $0.433B 0.00
DBV Technologies S.A (DBVT) France $0.430B 0.00
Anika Therapeutics (ANIK) United States $0.421B 14.48
Aquinox Pharmaceuticals (NLTX) United States $0.414B 0.00
Verastem (VSTM) United States $0.411B 0.00
Vericel (VCEL) United States $0.387B 57.47
Xenon Pharmaceuticals (XENE) Canada $0.384B 0.00
Agenus (AGEN) United States $0.383B 0.00
Scholar Rock Holding (SRRK) United States $0.381B 0.00
Cel-Sci (CVM) United States $0.374B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.373B 0.00
AnaptysBio (ANAB) United States $0.368B 0.00
Sorrento Therapeutics (SRNE) United States $0.366B 0.00
BioDelivery Sciences (BDSI) United States $0.364B 42.00
MiMedx (MDXG) United States $0.361B 0.00
UROGEN PHARMA (URGN) United States $0.355B 0.00
Cellectis S.A (CLLS) France $0.349B 0.00
Kala Pharmaceuticals (KALA) United States $0.346B 0.00
CytomX Therapeutics (CTMX) United States $0.340B 0.00
Cue Biopharma (CUE) United States $0.338B 0.00
PDL BioPharma (PDLI) United States $0.337B 10.11
Merus (MRUS) Netherlands $0.319B 0.00
Cellular Biomedicine (CBMG) United States $0.298B 0.00
Dynavax Technologies (DVAX) United States $0.298B 0.00
Pfenex (PFNX) United States $0.298B 435.00
Syndax Pharmaceuticals (SNDX) United States $0.295B 0.00
Puma Biotechnology (PBYI) United States $0.286B 0.00
Precision BioSciences (DTIL) United States $0.285B 0.00
WAVE Life Sciences (WVE) Singapore $0.279B 0.00
Avid Bioservices (CDMO) United States $0.264B 0.00
NantKwest (NK) United States $0.261B 0.00
Kamada (KMDA) Israel $0.252B 10.50
Syros Pharmaceuticals (SYRS) United States $0.249B 0.00
Mersana Therapeutics (MRSN) United States $0.244B 0.00
Sutro Biopharma (STRO) United States $0.235B 0.00
Albireo Pharma (ALBO) United States $0.234B 0.00
Stemline Therapeutics (STML) United States $0.234B 0.00
Gritstone Oncology (GRTS) United States $0.231B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.226B 0.00
Seres Therapeutics (MCRB) United States $0.225B 0.00
ADMA Biologics Inc (ADMA) United States $0.224B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.218B 0.00
Geron (GERN) United States $0.210B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.208B 0.00
Aduro Biotech (ADRO) United States $0.203B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.202B 1.82
MannKind (MNKD) United States $0.200B 0.00
Alcobra (ARCT) United States $0.192B 0.00
Starpharma Holdings (SPHRY) Australia $0.186B 0.00
ChromaDex (CDXC) United States $0.185B 0.00
XOMA (XOMA) United States $0.180B 0.00
Abeona Therapeutics (ABEO) United States $0.176B 0.00
Protagonist Therapeutics (PTGX) United States $0.171B 0.00
HOOKIPA Pharma (HOOK) United States $0.168B 0.00
Selecta Biosciences (SELB) United States $0.164B 0.00
VBI Vaccines (VBIV) United States $0.164B 0.00
IVERIC Bio (ISEE) United States $0.159B 0.00
Biofrontera AG (BFRA) Germany $0.159B 0.00
OSMOTICA PHARM (OSMT) United States $0.154B 0.00
Prometic Life Sciences (LMNL) Canada $0.151B 0.00
Kindred Biosciences (KIN) United States $0.151B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.150B 0.00
POXEL SA FRANCE (PXXLF) France $0.149B 0.00
Spero Therapeutics (SPRO) United States $0.148B 0.00
Liquidia Technologies (LQDA) United States $0.147B 0.00
Fortress Biotech (FBIO) United States $0.144B 0.00
Aytu Bioscience (AYTU) United States $0.143B 0.00
Dyadic (DYAI) United States $0.138B 0.00
AIT Therapeutics (XAIR) United States $0.136B 0.00
Theratechnologies (THTX) Canada $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
VolitionRX (VNRX) United States $0.133B 0.00
Windtree Therapeutics (WINT) United States $0.131B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.127B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.126B 0.00
Affimed (AFMD) Germany $0.125B 0.00
Cerecor (CERC) United States $0.123B 0.00
Antibe Therapeutics (ATBPF) Canada $0.120B 0.00
Exicure (XCUR) United States $0.118B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.117B 0.00
VTv Therapeutics (VTVT) United States $0.117B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.114B 4.49
Enzo Biochem (ENZ) United States $0.107B 0.00
Strongbridge Biopharma (SBBP) United States $0.105B 0.00
IBio (IBIO) United States $0.104B 0.00
Northwest Biotherapeutics (NWBO) United States $0.104B 0.00
Celyad SA (CYAD) Belgium $0.102B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.099B 0.00
Cidara Therapeutics (CDTX) United States $0.097B 0.00
Palatin Technologies (PTN) United States $0.096B 2.61
OvaScience (MLND) United States $0.091B 0.00
Aptinyx (APTX) United States $0.089B 0.00
TELA Bio (TELA) United States $0.088B 0.00
PHASEBIO PHARMA (PHAS) United States $0.087B 0.00
Orgenesis (ORGS) United States $0.081B 4.72
CorMedix Inc (CRMD) United States $0.080B 0.00
ARAVIVE, INC (ARAV) United States $0.078B 0.00
Five Prime Therapeutics (FPRX) United States $0.077B 0.00
Happiness Biotech Group (HAPP) China $0.077B 0.00
Clearside Biomedical (CLSD) United States $0.072B 0.00
Arbutus Biopharma (ABUS) Canada $0.069B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.069B 0.00
Eton Pharmaceuticals (ETON) United States $0.066B 0.00
Adocia (ADOCY) France $0.066B 0.00
Cyclerion Therapeutics (CYCN) United States $0.066B 0.00
Checkpoint Therapeutics (CKPT) United States $0.066B 0.00
Menlo Therapeutics (MNLO) United States $0.065B 0.00
Emmaus Life Sciences (EMMA) United States $0.059B 0.00
Applied Genetic Technologies (AGTC) United States $0.059B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.059B 0.00
Pluristem Therapeutics (PSTI) Israel $0.059B 0.00
Vaccinex (VCNX) United States $0.059B 0.00
SESEN BIO, INC (SESN) United States $0.058B 0.00
Proteostasis Therapeutics (PTI) United States $0.054B 0.00
AquaBounty Technologies (AQB) United States $0.053B 0.00
Synlogic (SYBX) United States $0.051B 0.00
Trevena (TRVN) United States $0.049B 0.00
Catalyst Biosciences (CBIO) United States $0.048B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.047B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.047B 0.00
Stealth BioTherapeutics (MITO) United States $0.046B 0.00
Vascular Biogenics (VBLT) Israel $0.044B 0.00
Acorda Therapeutics (ACOR) United States $0.041B 0.00
Idera Pharmaceuticals (IDRA) United States $0.038B 0.00
Cocrystal Pharma (COCP) United States $0.038B 0.00
Soligenix (SNGX) United States $0.035B 0.00
AmpliPhi Biosciences (ARMP) United States $0.034B 0.00
Organovo Holdings (ONVO) United States $0.033B 0.00
Protalix BioTherapeutics (PLX) Israel $0.033B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.032B 0.00
Lumos Pharma (LUMO) United States $0.032B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.032B 0.00
CollPlant Holdings (CLGN) Israel $0.032B 0.00
Advaxis (ADXS) United States $0.032B 0.00
DiaMedica Therapeutics (DMAC) United States $0.031B 0.00
Celldex Therapeutics (CLDX) United States $0.029B 0.00
Prima BioMed (IMMP) Australia $0.028B 0.00
Celsion (CLSN) United States $0.027B 0.00
Pulmatrix (PULM) United States $0.026B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.025B 0.00
TOCAGEN INC (TOCA) United States $0.025B 0.00
Curis (CRIS) United States $0.024B 0.00
Evogene (EVGN) Israel $0.024B 0.00
BioCardia (BCDA) United States $0.023B 0.00
Signal Genetics (MGEN) United States $0.022B 0.00
Entera Bio (ENTX) Israel $0.022B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.022B 0.00
Novogen (KZIA) Australia $0.019B 0.00
Stellar Biotechnologies (EDSA) Canada $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
Oncobiologics (OTLK) United States $0.017B 0.00
Alimera Sciences (ALIM) United States $0.017B 0.00
Apricus Biosciences (SEEL) United States $0.015B 0.00
Titan Pharmaceuticals (TTNP) United States $0.015B 0.00
VIVUS (VVUS) United States $0.014B 0.00
Cesca Therapeutics (THMO) United States $0.011B 0.00
Unum Therapeutics (UMRX) United States $0.011B 0.00
AEterna Zentaris (AEZS) United States $0.011B 0.00
Aptevo Therapeutics (APVO) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
ATyr Pharma (LIFE) United States $0.010B 0.00
Bionano Genomics (BNGO) United States $0.010B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
TrovaGene (TROV) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
TRACON Pharmaceuticals (TCON) United States $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
IMMURON (IMRN) Australia $0.006B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Spherix (AIKI) United States $0.003B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00